Table 1 Baseline characteristics (n = 161)
Age (years) | 67.0 ± 9.4 (32 – 86) |
Female (%) | 20.5 |
Ischemic cardiomyopathy (%) | 53.4 |
NYHA functional class | 3.1 ± 0.5 (2 – 4) |
- NYHA II (%) | 8.1 |
- NYHA III (%) | 70.8 |
- NYHA IV (%) | 21.1 |
LVEF (%) | 24.7 ± 5.1 (15 – 35) |
LVESD (mm) | 57.1 ± 8.2 (37 – 90) |
LVEDD (mm) | 66.4 ± 7.6 (45 – 96) |
Mitral regurgitation (grade) | 1.9 ± 1.1 (1 – 4) |
NT-proBNP (pg/ml) | 4221 ± 5563 (270 – 35000) |
Atrial fibrillation (%) | 14.3 |
ICD (%) | 67.1 |
QRSd (ms) | 157 ± 20 (120 – 211) |
QLV (ms) | 117 ± 28 (65 – 189) |
QLV ratio | 0.74 ± 0.12 (0.46 – 0.95) |
Baseline medication | |
- Beta-blockers (%) | 96 |
- ACEI or ARB (%) | 99 |
- Loop diuretics (%) | 91 |
- Aldosterone antagonists (%) | 89 |